glp-1 news today october 23 2025 Consumers' Expectations about Drugs Economic Impact on Food System Players GLP-1 RA prescription trends: January

No, back pain is not listed among the common or very common adverse reactions in the MHRA-approved Summary of Product Characteristics for Rybelsus

If side effects become severe or do not go away, speak to your doctor

They started making synthetic analogs, lab-built versions that work like GLP-1 but dont break down so fast

Manufacturers have substantially expanded production capacity and supply has gradually improved for most products through 2024 into 2025

One focuses on gastroparesis, with the other focusing on vision loss

Legal claims assert that GlaxoSmithKline, the manufacturer of Alli, did not properly warn users about the potential for liver toxicity, especially among individuals with preexisting conditions or those who were using the drug for extended periods